Your SlideShare is downloading. ×
Cystic lesions of the pancreas
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Cystic lesions of the pancreas


Published on

  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Dr. Ketul V. Shah1st year MCh G.I.Surgery resident V.S. Hospital, Ahmedabad Discussion; Dr Sanjay Nagral, Consultant GI surgeon,Mumbai.
  • 2. Cystic lesion in Pancreas Task aheadI. Is the lesion from pancreas?II. Lesion is solid or cystic?III. Neoplastic v/s non-neoplastic?IV. SCA v/s MCN v/s IPMN?V. Management?
  • 3. CASE HISTORY 45y/F c/o recurrent vomiting and loss of appetite - 6 mths.  Vomitus contained food and occurred ½ to 1 hour after meals & was non-bilious, non-projectile h/o diffuse abdominal pain significant weight loss ++ Anorexia ++
  • 4.  There was no preceding history of any severe abdominal pain or jaundice No h/o lump in abdomen, abdominal distension Pt is not a k/c/o diabetes and no other positive medical or surgical history
  • 5. ON EXAMINATION pallor +, No LNpathy P/A- soft, non tender, no palpable lump, no organomegaly. No ascitis. other systems normal.
  • 6. INVESTIGATIONS DONE LFT – wnl S. Amylase and Lipase were normal USG - A cystic lesion in the pancreatic head and neck region of about 7x5cm CECT - 73x60 mm cystic lesion in pancreatic head & neck region; cystic wall-3mm; MPD- normal; no peri-pancreatic LN or fluid. S. CA 19-9 – wnl S. CEA - wnl
  • 7. While approaching a cystic lesionswe need to know…. Broad differential diagnosis Epidemiology of common lesions Clinical presentation Blood tests Imaging Histology
  • 8. Broad D/D’s of Cystic Pancreatic Lesions1) Pseudocyst (75-80%)2) Common cystic pancreatic neoplasms  Mucinous cystic neoplasm (10-45%)  Serous cystic neoplasm (32-39%)  IPMN (21-33%)3) Rare cystic pancreatic neoplasms  Solid pseudopapillary tumor (<10%)  Acinar cell cystadenocarcinoma (<!%)  Lymphangioma  Hemangioma  Paraganglioma
  • 9. 4) Solid pancreatic lesions with cystic degeneration  Pancreatic adenocarcinoma (<1%)  Cystic islet cell tumor (insulinoma, glucagonoma, gastrinoma) (<10%)  Metastasis  Cystic teratoma  Sarcoma5) Hydatid cyst6) Lymphatic cyst7) True epithelial cysts a/w-  von Hippel–Lindau disease  autosomal -dominant polycystic kidney disease
  • 10. Imaging in Cystic lesions…. As against Solid lesions, Imaging may be diagnostic in many cystic lesions, obviating further investigations
  • 11. Imaging in cystic lesions of pancreas;How does it help???
  • 12. Four Morphologic Types of Cystic Lesions of the Pancreas
  • 13. a) Unilocular Cyst Pseudocyst- most commonOther causes- IPMN occasionally Unilocular serous cystadenoma Lymphoepithelial cyst Multiple  von Hippel-Lindau  Pseudocysts
  • 14. b) Microcystic Lesions Serous cystadenoma(Only lesion included in this category)
  • 15. c) Macrocystic Lesions Mucinous cystic neoplasms Intraductal Papillary Mucinous Neoplasm (IPMN)
  • 16. d) Cysts with a solid component- Unilocular or multilocular True cystic tumors or solid pancreatic neoplasms with cystic component/degeneration  Solid pseudopapillary tumor (SPEN)  Mucinous cystic neoplasms  IPMNs  Islet cell tumor  Adenocarcinoma  Metastasis
  • 17. Let us look at the possibilities inour patient……
  • 18. Could this patient have PANCREATIC PSEUDOCYST? Symptoms  Abdominal pain (80 – 90%)  Lump in abdomen  Nausea / vomiting ( due to gastric or duodenal compression)  Early satiety  Bloating, indigestion  Jaundice ( due to compression of bile duct)  Hemorrhage Signs  Tenderness  Abdominal fullness  Palpable mass
  • 19. Blood tests in suspectedpseudocyst Amylase/Lipase
  • 20. Imaging in Pseudocyst….. Ultrasonography  Most practical & Sensitivity 75 – 90%  limited by patient habitus, operator experience and air in stomach CT scan  Gold standard for initial assessment and follow-up  Sensitivity  90- 100% MRI  Better detail of content of cyst MRCP  Establish the relationship of the pseudocyst to the pancreatic ducts Endoscopic Ultrasonography (EUS +/- FNA)  Distinguishing pancreatic cystic lesions, helps in FNA
  • 21. So, if you have a cystic lesionswith….. Sudden onset of pain consistent with pancreatitis pain Imaging features of associated pancreatitis Unilocular cyst; and Elevated amylase/lipase You may not investigate any further…… It must be a pseudocyst
  • 22. Common neoplastic lesions and their features….
  • 23. Cystic neoplasm of pancreas
  • 24. MUCINOUS CYSTIC NEOPLASMS Most common - 10% to 45% (MCA -67%, MCAC - 33%) > 95% in women ( Mean ~ 50 yrs) Typically involve the body and tail of the pancreas Never multifocal, occurring only in one location within the pancreas.
  • 25.  Asymptomatic in 75% cases  If symptoms, usually due to mass effect  Adominal pain  Palpable mass
  • 26.  CT or MRI of the abdomen  Complex macrocystic mass with internal septations  MRCP no communication between duct and the cyst  Contrast enhanced scans show enhancement of the cyst wall and accentuate any septations and mural nodules  Distal to the tumor, the pancreas may show changes of CP  Presence of mural nodule and septal calcification s/o – malignancy
  • 27.  EUS can identify septations and cyst wall nodules in more detail than MRI or CT Allows cyst wall biopsy and cyst fluid aspiration for analysis Cyst fluid analysis generally reveals  thick and mucoid material and low fluid amylase  elevated tumor markers (CEA)  mucinous epithelial cells by cytology
  • 28. Mucinous Cystadenocarcinoma Complex macrocystic lesion with internal septations Peripheral and septal calcification indicative of malignancy (arrowheads)
  • 29. SEROUS CYSTADENOMAS Second MC Cystic tumor of the pancreas  formerly known as microcystic adenomas Occurring mostly in women (75%) with a mean 62 years Most (50% to 70%) occur in the body or tail of the pancreas An association with von Hippel-Lindau disease
  • 30.  Mostly asymptomatic  being detected during evaluation for other unrelated conditions Can present with a palpable mass - size (10 to 25 cm)
  • 31. Serous Cystadenoma Lesion with numerous microcysts giving a “honey-comb” appearance Lobulated outline Central stellate scar
  • 32. Serous cystadenoma Pathognomonic image by CT scan is that of a spongy mass with a central “sunburst” calcification - only 10% of patients Visualization of four of the following five CT and MRI features aid in making the diagnosis  location in the pancreatic body and tail  wall thickness < 2 mm  lobulated contour  lack of communication with the pancreatic duct  minimal wall enhancement
  • 33. IPMN(Intra-ductal Papillary Mucinous Neoplasm) Types - depend on involvement of duct  main pancreatic duct, isolated side branches, or a combination of both Benign (adenoma), borderline, or malignant Malignant neoplasms account for 60% of IPMNs
  • 34. IPMN FEATURES Equal frequency in men and women Median age at diagnosis - about 65 years 75% of patients are symptomatic  Abdominal pain and weight loss – MC complaints  Recurrent pancreatitis or  Acute pancreatitis Patients with malignant neoplasms are more likely to be  older and more likely to present with jaundice or new-onset diabetes
  • 35. DIAGNOSIS Differentiation of IPMN from other cystic pancreatic masses may be difficult at CT Most reliable findings for the diagnosis  Presence of a communication between the cystic lesion and the main pancreatic duct Presence of mural nodules projecting into the main pancreatic duct or cystic lesions
  • 36. DIAGNOSIS Diffusely distended pancreatic duct with mucinous filling defects and grape-like, cystic, space-occupying lesions Sensitivity in diagnosing an IPMN  highest for MRI with MRCP (88%),followed by ERCP (68%) and CT (42%)
  • 37.  Pathognomonic for IPMN in ERCP  A wide and gaping papilla with secretion of mucin and filling defects in the dilated pancreatic duct –FISH MOUTH AMPULLA
  • 38. Cystic lesions of pancreas; will blood tests help ? Amylase and/or Lipase?? CEA? Ca 19-9 ??Not diagnostic of any of the cystic pancreatic tumorsOnly provide corroborative evidence
  • 39. Serum amylase or lipase levels Increased - pseudocyst, IPMNSerum CA 19-9 & CEA normal - benign cystic pancreatic tumors modestly elevated - MCNs and IPMNs, particularly patients with malignancies Markedly elevated -retention cyst secondary to obstruction of the main pancreatic duct by an adenocarcinoma.
  • 40. Cystic lesions of Pancreas; willaspiration and analysis of fluid help?
  • 41. Cyst Fluid Analysis Viscosity Amylase Cytology Pseudocyst Low High Inflamm. SCA Low Low 5% + MCA High Low 40% + MCAC High Low 67% + CEA CA 15-3 CA 72-4 Pseudocyst Low Low Low SCA Low Low Low MCA High High Low MCAC High High High[1] Lewandrowski KB, et al. Ann Surg 1993, 217:41-7.[2] Brugge WR, et al. N Engl J Med 2004, 351:1218-26.
  • 42. Coming back to our case…
  • 43. Our patient has…. No clear cut diagnosis on history Serum markers were non-informative Imaging not diagnostic Therefore EUS guided FNA was done..……Adenocarcinoma with cystic degeneration
  • 44. DR. KETUL SHAH